Status:

ACTIVE_NOT_RECRUITING

Multivitamin for Health and Cognition

Lead Sponsor:

Dr Anthony Hobson

Collaborating Sponsors:

Heights

Conditions:

Healthy

Cognition

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

Multiple factors contribute to poor mental and cognitive health including well-balanced nutrition. This research project will aim to establish whether a the multivitamin Vitals+ is more effective in i...

Eligibility Criteria

Inclusion

  • Participant has provided written informed consent before participating in the study after being given a full description of the study and prior to any study-specific procedures being performed.
  • Participant has no significant medical diagnosis (health individuals)
  • Participant takes no regular prescription medication
  • Participant is not undertaking any restrictive diet (e.g. Carnivore, Low FODMAP)
  • Participant agrees to adhere to guidance on fortified food intake for the duration of the study
  • Participant is a male or non-pregnant female and is 18-70 years of age
  • If WOCBP participant is willing to adhere to one of the following methods of contraception i) Hormonal contraception e.g. the 'pill' or an implant ii) Intrauterine device (IUD) iii) Intrauterine hormone-releasing system (IUS) iv) Hysterectomy v) Vasectomised partner vi) Sexual abstinence (if it is in line with your preferred and usual lifestyle).
  • Participant can communicate well with the Investigator and to comply with the requirements for the entire study.
  • Participant has capacity to understand written English.
  • Participant has a body mass index (BMI) of 18.5 - 39.9kg/m2 (bounds included).
  • Participant agrees to follow all pre-test preparation before L/M-HMBT testing.

Exclusion

  • Participant has consumed nutritional supplement in the past 3 months
  • Diagnosis of any current medical condition, except visual impairment and other conditions at the discretion of the investigator
  • Participated in a trial of an investigational medical product or medical device in the last 28 days.
  • Females who report to be pregnant or lactating
  • Prior abdominal surgery
  • Unwilling to maintain a stable diet for the duration of the trial.
  • Unable to comply with limiting fortified food intake to \<5 portions per week for the duration of the study
  • Being in the opinion of the investigator unsuitable
  • Insufficient knowledge of English to complete the daily bowel diary and food diary.
  • Hypersensitivity to any component of the supplement
  • Hypersensitivity or known allergy to lactulose or mannitol.
  • Consumption of oral antibiotics in the last 4 weeks.
  • NSAIDs for 2 weeks prior to and during the entire 90 day study period. Participant should not be a chronic NSAID user (\>1 day/week).
  • Gastrointestinal infection in the past 4 weeks.
  • IV vitamin/mineral therapy in the past 12 weeks
  • Use of medical devices for the purpose of cognitive enhancement, such as neural stimulation, in the 2 weeks prior or during the study period
  • Participant is involved in this study as an Investigator, sub-Investigator, study coordinator, other study staff, or Sponsor member.

Key Trial Info

Start Date :

July 7 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT07145658

Start Date

July 7 2025

End Date

December 1 2025

Last Update

December 1 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

The functional gut clinic

London, United Kingdom, NW16PU

2

The functional gut clinic

Manchester, United Kingdom, m34bg